Markets.com Logo

AARTIDRUGS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    498.2748$
  • Previous Close
    488.1394$
  • 52 Week Change
    252.05$
  • Day Range
    10.14$
  • 52 Week High/Low
    312$ - 564.05$
  • Dividend Per Share
    0
  • Market cap
    44 823 M$
  • EPS
    8.07
  • Beta
    0.16
  • Volume
    --

About

AARTIDRUGS.NSE represents the equity stock of Aarti Drugs Limited, traded on the National Stock Exchange of India (NSE). Aarti Drugs is a pharmaceutical company engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, and specialty chemicals. Investing in this stock allows shareholders to participate in the company's financial performance and receive potential returns through dividends and capital appreciation. The stock's price fluctuates based on market sentiment, company performance, and broader economic conditions.
Ethereum price prediction 2026: What’s driving Ethereum’s value (ETH/USD)?

Ethereum price prediction 2026: What’s driving Ethereum’s value (ETH/USD)?

Ghko B|--
Gold price (XAU/USD) rises to new ATH: Will gold keep going up in 2026?

Gold price (XAU/USD) rises to new ATH: Will gold keep going up in 2026?

Ghko B|--
Best EV stocks to buy in 2026: Rivian stock, Lucid stock, NIO, TSLA stock

Best EV stocks to buy in 2026: Rivian stock, Lucid stock, NIO, TSLA stock

Ghko B|--
Trending AI stocks analysis: Could Nebius (NBIS) stock doble in 2026?

Trending AI stocks analysis: Could Nebius (NBIS) stock doble in 2026?

Ghko B|--
Stellar XLM price prediction: Could XLM/USD reach $1 in 2026?

Stellar XLM price prediction: Could XLM/USD reach $1 in 2026?

Ghko B|--
NVIDIA soars 39% in 2025: Will NVDA stock surge to $250 in 2026?

NVIDIA soars 39% in 2025: Will NVDA stock surge to $250 in 2026?

Ghko B|--
Tesla stock crashes 4% on Q4 results: Is NASDAQ: TSLA stock overvalued?

Tesla stock crashes 4% on Q4 results: Is NASDAQ: TSLA stock overvalued?

Ghko B|--

Factors

[Company Performance]: Financial results like revenue, profit margins, and earnings per share significantly impact investor confidence.

[Industry Trends]: Growth or decline in the pharmaceutical sector, regulatory changes, and competition affect stock valuation.

[Market Sentiment]: Overall investor mood, economic outlook, and global events influence buying and selling pressure.

[Regulatory Approvals]: Success or failure in obtaining regulatory approvals for new drugs affects future revenue potential.

[Raw Material Prices]: Fluctuations in the cost of raw materials used in drug manufacturing impact profit margins.

[Currency Fluctuations]: Exchange rate changes can affect the revenue and profitability of the company, especially with exports.

[Competition]: Competitive landscape, including new entrants and pricing strategies, influences market share and profitability.

[Research and Development]: Investment in R&D and the success of new product development determine future growth prospects.

[Management Decisions]: Strategic decisions made by the company's management team, such as acquisitions and expansions.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

What is FTSE 100 Index: How to trade FTSE 100 Index CFDs with markets.com?

What is FTSE 100 Index: How to trade FTSE 100 Index CFDs with markets.com?

Ghko B|--
Moving average indicator: What is the best indicator for moving average?

Moving average indicator: What is the best indicator for moving average?

Ghko B|--
What is the Russell 2000: How to start trading the Russell 2000 Index?

What is the Russell 2000: How to start trading the Russell 2000 Index?

Ghko B|--